iWand P

Posterior Manual Radionuclide Applicator

Key Features

  • The LV Y-90 Disc resides within a custom-fitted well on the inner surface of the iWand P.
  • The applicator tip has been designed to be as slender and smooth as possible, so its introduction posterior to the eye and peri-ocular maneuverability is maximized.
  • Note the 4 guiding lights located around and thus encircling the LV Y-90 Disc source. Once inserted behind the eye, these lights are ophthalmoscopically and photographically visible as distinct spots, surrounding and thus defining the treatment area.
  • The curved shape of the wand shaft has been developed to give optimal conformity with the eye and surrounding orbit.
  • The handle is shaped to give excellent control and feel during the application.
  • The entire applicator weighs less than 8 grams, less than most pens, thus keeping fatigue to a minimum.
  • The connection to the regulated, filtered LV light source unit is via 3 meters of thin fiber optic cable which keeps any electronics far from the surgery.

Liberty Vision has developed the iWand® P to be a simple device for treating intraocular tumors and benign growths.

The iWand P has been specially designed to treat posterior ocular tumors and growths. Optimized for episcleral, extraocular placement of beta radiation, the iWand P holds the patent pending LV Y-90 Disc. Posterior application will require a conjunctival opening to insert the device. Liberty Vision makes viewing of the source behind the eye possible by incorporating four guiding lights surrounding the LV Y-90 Disc source. Ophthalmoscopy (indirect or photographic) can be used to view and thus guide the four lights and thus the disc beneath the targeted zone. The iWand P lights circumscribe the target, offering direct, recordable confirmation of LV Y-90 Disc source’s location during treatment. Like the anterior model, each superlight iWand P is individually packaged and is sterile for single use.


Want to learn more?

Read: Liberty Vision’s Y-90 Radiation System is not just for eye cancer